These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7901268)

  • 1. Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis.
    Kürktschiev D; Subat S; Adler D; Schentke KU
    J Hepatol; 1993 Jul; 18(3):373-7. PubMed ID: 7901268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dipeptidyl peptidase IV of peripheral blood lymphocytes in patients with primary biliary cirrhosis].
    Adler D; Kürktschiev D; Subat S; Lehmann HU; Schentke KU
    Z Gastroenterol; 1993 Feb; 31(2):135-9. PubMed ID: 8096665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production.
    Reinhold D; Bank U; Bühling F; Neubert K; Mattern T; Ulmer AJ; Flad HD; Ansorge S
    Immunobiology; 1993 Aug; 188(4-5):403-14. PubMed ID: 7902330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dipeptidyl-peptidase IV of human lymphocytes in patients with primary biliary cirrhosis and UDCA therapy].
    Kürktschiev D; Adler D; Subat S; Lehmann HU; Schentke KU
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():104-5. PubMed ID: 7483686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy.
    Lim AG; Wolfhagen FH; Verma A; van Buuren HR; Jazrawi RP; Levy JH; Northfield TC; Schalm SW
    Eur J Gastroenterol Hepatol; 1997 Feb; 9(2):155-61. PubMed ID: 9058626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful immunomodulating in AIDS patients with ursodeoxycholic acid--a pilot study.
    Kurktschiev D; Temelkova-Kurktschiev T; Horn K; Schentke K
    Clin Exp Immunol; 1999 Jan; 115(1):144-6. PubMed ID: 9933434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory effects of ursodeoxycholic acid on immune responses.
    Yoshikawa M; Tsujii T; Matsumura K; Yamao J; Matsumura Y; Kubo R; Fukui H; Ishizaka S
    Hepatology; 1992 Aug; 16(2):358-64. PubMed ID: 1639344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis.
    Leevy CB; Holt J; Buniak B
    J Assoc Acad Minor Phys; 1993; 4(1):30-2. PubMed ID: 8425102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of human T lymphocytes identified by antibodies to dipeptidyl peptidase IV on differentiation of human B lymphocytes stimulated with Staphylococcus aureus Cowan I and pokeweed mitogen.
    Gruber M; Scholz W; Flad HD
    Cell Immunol; 1988 May; 113(2):423-34. PubMed ID: 2896071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes.
    Schön E; Mansfeld HW; Demuth HU; Barth A; Ansorge S
    Biomed Biochim Acta; 1985; 44(2):K9-15. PubMed ID: 2860900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination.
    Fracchia M; Secreto P; Tabone M; Zaffino C; Pera A; Galatola G
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):463-8. PubMed ID: 10784002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.
    Chowdhury S; Chen Y; Yao TW; Ajami K; Wang XM; Popov Y; Schuppan D; Bertolino P; McCaughan GW; Yu DM; Gorrell MD
    World J Gastroenterol; 2013 May; 19(19):2883-93. PubMed ID: 23704821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
    Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
    Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV in the immune system. Cytofluorometric evidence for induction of the enzyme on activated T lymphocytes.
    Schön E; Ansorge S
    Biol Chem Hoppe Seyler; 1990 Aug; 371(8):699-705. PubMed ID: 1698386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy.
    Terasaki S; Nakanuma Y; Ogino H; Unoura M; Kobayashi K
    Am J Gastroenterol; 1991 Sep; 86(9):1194-9. PubMed ID: 1882800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
    Makino I
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
    [No Abstract]   [Full Text] [Related]  

  • 18. Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
    Nishigaki Y; Ohnishi H; Moriwaki H; Muto Y
    Dig Dis Sci; 1996 Jul; 41(7):1487-93. PubMed ID: 8689929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid.
    Abbas G; Lindor KD
    Expert Opin Pharmacother; 2010 Feb; 11(3):387-92. PubMed ID: 20102304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
    Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
    Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.